Literature DB >> 1274009

Bacterial prostatitis: treatment with trimethoprim-sulfamethoxazole.

E J McGuire, B Lytton.   

Abstract

Fifteen patients with chronic bacterial prostatitis were treated with trimethoprim-sulfamethoxazole for three months. In 60 per cent of the patients a recurrence of chronic bacterial prostatitis developed during a follow-up period of from one to two and one-half years. It appears that factors other than a diffusion barrier to effective antimicrobial agents into the prostatic gland are responsible for the persistence of chronic bacterial infections of the prostate.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1274009     DOI: 10.1016/0090-4295(76)90189-8

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  7 in total

1.  Pharmacokinetics of quinolone derivatives in the prostate.

Authors:  P O Madsen; J Aagaard
Journal:  Infection       Date:  1991       Impact factor: 3.553

Review 2.  The role of quinolones in the treatment of chronic bacterial prostatitis.

Authors:  K G Naber
Journal:  Infection       Date:  1991       Impact factor: 3.553

3.  Anti-inflammatory and Antimicrobial Effects of Anthocyanin Extracted from Black Soybean on Chronic Bacterial Prostatitis Rat Model.

Authors:  Byung Il Yoon; Woong Jin Bae; Yong Sun Choi; Su Jin Kim; U Syn Ha; Sung-Hoo Hong; Dong Wan Sohn; Sae Woong Kim
Journal:  Chin J Integr Med       Date:  2013-10-14       Impact factor: 1.978

4.  The treatment of chronic bacterial prostatitis.

Authors:  A Pfau
Journal:  Infection       Date:  1991       Impact factor: 3.553

5.  Co-trimoxazole or trimethoprim alone? A viewpoint on their relative place in therapy.

Authors:  W Brumfitt; J M Hamilton-Miller
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

6.  Moxalactam concentrations in human prostatic tissue.

Authors:  R P Smith; H Wilbur; N T Sutphen; A L Baltch
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

Review 7.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.